2014 Annual Meeting | 1SM.002 - Practice Survival for Neurologists: Business Strategies for Success

Date Saturday 04/26/14

Time 03:00 PM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Brad C. Klein, MD, MBA, FAAN

Topic(s)

Learning Objectives Participants should be able to understand practice revenues, expenses, and cash flow; identify revenue cycle problems; establish and use key performance indicators for their practices; enhance work flow to maintain fiscal health; utilize benchmarking to enhance their practice; know and address basic legal issues in setting up and running a practice; understand how to choose and use technology at point of care; evaluate the economics of outsourcing versus providing in-house services; utilize financial analysis to determine if technology and other capital investments will provide a return on investment; know how to determine which payers are creating an administrative drain on their practices; identify possible fraud internally within the practice; and understand how to evaluate and implement new financial reimbursement and risk-sharing management models such as accountable care organizations.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Practice-based Learning and Improvement

Recommended Audience Other, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Didactic, Interactive

Event Timeline
03:00 PM - 03:50 PM		Neurology Practice Basics: Understand Practice Data Reporting, Financial Management, Benchmarking Your Practice for Success, and Insurance Contract Negotiations Brad C. Klein, MD, MBA, FAAN
03:50 PM - 04:00 PM		Questions and Answers Brad C. Klein, MD, MBA, FAAN
04:00 PM - 04:50 PM		Advanced Neurology Practice Management: preparing your practice for value-based care and population management Gregory J. Esper, MD, MBA, FAAN
04:50 PM - 05:00 PM		Questions and Answers Gregory J. Esper, MD, MBA, FAAN

Faculty Disclosures
Brad C. Klein, MD, MBA, FAAN	Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly and Company. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AbbVie. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly and Company. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biodelivery Science. The institution of Dr. Klein has received research support from AbbVie. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Shareholder with AppsbyDocs, LLC. Dr. Klein has a non-compensated relationship as a Chair, Practice Management Committee with American Headache Society that is relevant to AAN interests or activities.
Gregory J. Esper, MD, MBA, FAAN	Dr. Esper has stock in NeuroOne Medical Technologies, Inc. Dr. Esper has stock in Focused Cryo, Inc. The institution of an immediate family member of Dr. Esper has received research support from Centers for Disease Control. The institution of Dr. Esper has received research support from Health and Human Services Assistant Secretary for Preparedness and Response. An immediate family member of Dr. Esper has received publishing royalties from a publication relating to health care.